stimulus types, B1 significantly differed from all other groups at the occipital component and from HC and B3 at the centroparietal component (all p < .05). There was also a Biotype by task interaction at the late time bin of the centroparietal component, with reactivity to neutral images differing between B1 and B3 (p = .04) and reactivity to emotional images differing between B2 and HC (p = .04, .03). Discussion: Distinguishing patients by Biotype yielded new information regarding emotional scene perception in psychosis. Only one neural measure distinguished between DSM-defined groups and did not interact with emotional scene content. However, these same measures and other components of the neural emotional response presented a complex pattern of differences within psychosis Biotypes. Results indicate the most profound disruptions in scene processing are found in B1. B1 is also associated with reductions in amygdala volume, which could result in abnormal aversive and appetitive reactions captured by these scalp measures of the emotional response. This external measure of neural function provides novel evidence that psychosis Biotypes identified by the BSNIP consortium provide better separation between psychosis subtypes than current DSM categories. Future research will examine habituation to scenes, medication effects, subjective reports of emotional experience, and clinical and phenotypic correlates.
O9.6. SIX MONTH LONGITUDINAL FEASIBILITY STUDY USING A SMARTPHONE APP (EXPRESS) TO ASSESS EARLY SIGNS AND BASIC SYMPTOMS AS PUTATIVE PREDICTORS OF PSYCHOSIS RELAPSE
Emily Eisner* ,1 , Richard Drake 1 , Natalie Berry 1 , Richard Emsley 2 , Christine Barrowclough 1 , Sandra Bucci 1 1
University of Manchester; 2 King's College London
Background: Psychosis relapses are common, have profound adverse consequences for patients, and are costly to health services. 'Early signs' have been used to predict relapse, in the hope of prevention or mitigation, with moderate sensitivity and specificity. To improve predictive power, we investigated adding 'basic symptoms' to conventional early signs and using a smartphone app to facilitate prompt identification of these. Methods: Individuals who had experienced a relapse of psychosis within the past year (n=22) took part in a screening interview. Those with at least one basic symptom emerging prior to a previous relapse (n=19; 86%) were eligible for the longitudinal feasibility study. Consenting participants (n=18) were asked to use a smartphone app ('ExPRESS') weekly for six months to report early signs, basic symptoms and psychotic symptoms. When app responses indicated an increase in psychotic symptoms above a pre-defined threshold, the researcher conducted the PANSS positive symptoms interview over the telephone to assess whether the symptom increase was indicative of relapse (in combination with a management change, evidenced by casenote review). On completion of, or dropout from, the app-use phase, participants were invited to give their views on the acceptability of the app and study procedures in a qualitative interview. Results: Participants completed 65% of app assessments and 58% of telephone interviews over the 6-month follow-up period. Completion of app assessments declined as the study progressed (OR=0.89 per week follow-up; p<0.001). Percentage app completion was significantly and inversely correlated with baseline depression (ρ=-0.56, p=0.015) and fear of relapse (ρ=-0.58, p=0.014). App items showed high concurrent validity with researcher-rated psychotic symptoms (ρ range 0.80 to 0.87, p<0.001) and basic symptoms (ICC=0.76, p<0.001) over six months. There was excellent agreement between telephone call and face-to-face assessed psychotic symptoms (ICC range 0.94 to 0.96, p<0.001). The primary relapse definition, based on telephone assessment and casenotes, compared well with a casenote-only definition but had better specificity (κ=0.76, p=0.003). Mixed-effects models (>200 observations) provided preliminary evidence of predictive validity: early signs and basic symptoms were associated with most app-assessed psychotic symptom variables the same week and three weeks later and adding basic symptoms to early signs improved model fit in most cases. Qualitative interviews indicated that both the app and study procedures were acceptable to patients with psychosis. Discussion: This study demonstrates that weekly app-based monitoring is feasible, valid and acceptable over a six-month period. It also provides a novel approach to operationally defining relapse by using a combination of telephone interviews and casenotes. We suggest that remote relapse assessment is more easily integrated into participants' everyday lives, decreasing both participant and researcher burden; this is likely to increase engagement and allow more frequent and long-term monitoring.
O9.7. THE COMPLEMENTARY ROLES OF COGNITION AND SUPPORTED EDUCATION/ EMPLOYMENT IN THE EARLY COURSE OF SCHIZOPHRENIA
Keith Nuechterlein* ,1 , Kenneth Subotnik 1 , Joseph Ventura 1 , Luana Turner 1 , Deborah Becker 2 , Robert Drake 2 1 University of California, Los Angeles; 2 Westat Background: Strong empirical evidence has indicated that the severity of cognitive deficits predicts functional outcome in the early course of schizophrenia, while equally strong evidence has shown that supported employment and supported education can substantially increase the proportion of first-episode psychosis patients who return to school or work. How do these influences on the early course of work/school outcome interface? Methods: Within a randomized controlled trial of Individual Placement and Support (IPS) and a Workplace Fundamentals Module (IPS-WFM) vs. conventional vocational rehabilitation plus social skills training with 69 individuals with a recent first episode of schizophrenia, we examined both supported employment/education and cognitive deficits in relationship to work/school outcome. A cognitive battery was administered at baseline and after 6 months of randomization to IPS vs. conventional vocational rehabilitation. To examine whether cognitive deficit level at baseline predicted work/school recovery in the context of these treatment conditions, we used as summary scores the first principal component as an overall index of cognitive deficit and the first rotated principal component, a processing-speed/ attention factor. We also examined individual cognitive test scores to determine whether IPS-WFM impacted cognitive deficit level. Results: Within 6 months after randomization, 83% of patients in the IPS-WFM intervention participated in competitive employment or school, compared to 41% in the conventional vocational rehabilitation group (p < .005), indicating a strong impact of supported employment/education. Overall level of baseline cognitive deficit significantly predicted participation in competitive work or school by 6 months in the entire sample (r=0.45, p<.002) as well as separately within the IPS-WFM group (r=0.35, p=.05) and the comparison group (r=0.60, p<.03). Using the Work Personality Profile factors to index work/school performance, we found that the baseline processing-speed/attention factor predicted Task Orientation, Work Motivation, and Social Skills in the full sample (r = 0.47, 0.54, and 0.65, respectively, all p<.01) and in the p<.06; r=0.54, p<.01; r=0.68, p<001, respectively) . We found no significant impact of IPS-WFM vs. conventional vocational rehabilitation on cognitive performance from baseline to 6 months. Discussion: Supported employment/education strikingly improves the odds of returning to work or school after a first psychotic episode. Cognitive deficit levels are not altered, however, and baseline cognitive deficit level continues to play a role in predicting both return to work or school and the quality of work/school performance even in the presence of this enhanced vocational rehabilitation strategy. This pattern of results suggests that supported employment/education is a powerful compensatory intervention that can override in many cases the role of cognitive deficits in limiting return to work or school. Other complementary interventions are likely to be needed to improve the persistent cognitive deficits. ) from initiation of CBTp to discharge (or at time of data collection). Fourteen patients rated subjective distress and interference in functioning secondary to symptoms, satisfaction with CBTp group and utility of skills learned. Results: On average, participants attended 32.0 (27.2) groups, or 70.6% of groups offered. Moderate to high engagement across sessions was observed in 84% of the sample. Analyses of change from initiation of CBTp to endpoint yielded significant reduction in distress secondary to symptoms on both clinician ratings (W=666, p<0.001) and the CGI (W=120, p<0.001), as well as significant improvement on the GAF scale (W=-666, p<0.001), with an average increase of over 25 points. Total BPRS scores decreased significantly (W= 255, p<0.001), with significant reductions also seen in the negative symptom subscale (p= 0.016), anxiety/depression (p= 0.002), hostility (p= 0.003) and thought disturbance (p= 0.002). Trends were noted for attendance and engagement relating to greater distress reductions, improvements in CDS, total BPRS scores, and GAF scores. On average patients indicated that they were satisfied to very satisfied with the group overall and reported that they agree to mostly agree that skills learned in group help them to feel better and function better. Discussion: From a recovery perspective, psychosocial treatments should emphasize distress reduction and improvement in adaptive functioning. Outcome measure selection should be consistent with the aims of the interventions. These findings indicate that individuals who participate in group CBTp demonstrate significant reductions in objective and subjective distress secondary to symptoms and in improvement in overall functioning. Moreover, participants report satisfaction with the group and report that the skills learned in group help them to cope with distress secondary to symptoms of the illness. Though change in total BPRS scores should be of interest (and reductions were indeed observed), this outcome should not be the primary, and certainly not the only focus when discussing efficacy
